pubmed-article:15094648 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15094648 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15094648 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
pubmed-article:15094648 | lifeskim:mentions | umls-concept:C0014591 | lld:lifeskim |
pubmed-article:15094648 | lifeskim:mentions | umls-concept:C0039445 | lld:lifeskim |
pubmed-article:15094648 | lifeskim:mentions | umls-concept:C0444498 | lld:lifeskim |
pubmed-article:15094648 | lifeskim:mentions | umls-concept:C0116757 | lld:lifeskim |
pubmed-article:15094648 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15094648 | pubmed:dateCreated | 2004-4-19 | lld:pubmed |
pubmed-article:15094648 | pubmed:abstractText | After a brief review of Rendu-Osler-Weber disease, we present the results from a series of 13 patients treated by Ethibloc injections for epistaxis. Based on a review of the literature, typical treatments are presented along with discussion of their efficacy and side effects. In our series, 90% of patients improved after only one injection. All patients reported a decrease in hemorrhage, especially patients with recurrent epistaxis. Five of nine patients reported a decrease in the length of the bleeding episodes. Improvement was reported by 85% of patients within one month following Ethibloc injection. Fifty percent of these patients have persistent good results at 4 Year follow-up. Our results indicate that Ethibloc injections are safe and effective as an alternative treatment for patients that have failed standard treatment options. | lld:pubmed |
pubmed-article:15094648 | pubmed:language | eng | lld:pubmed |
pubmed-article:15094648 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15094648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15094648 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15094648 | pubmed:month | Mar | lld:pubmed |
pubmed-article:15094648 | pubmed:issn | 0150-9861 | lld:pubmed |
pubmed-article:15094648 | pubmed:author | pubmed-author:DubinJJ | lld:pubmed |
pubmed-article:15094648 | pubmed:author | pubmed-author:LaccourreyeLL | lld:pubmed |
pubmed-article:15094648 | pubmed:author | pubmed-author:Pasco-PaponAA | lld:pubmed |
pubmed-article:15094648 | pubmed:author | pubmed-author:Roux-Vaillard... | lld:pubmed |
pubmed-article:15094648 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15094648 | pubmed:volume | 31 | lld:pubmed |
pubmed-article:15094648 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15094648 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15094648 | pubmed:pagination | 110-5 | lld:pubmed |
pubmed-article:15094648 | pubmed:dateRevised | 2008-2-20 | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:meshHeading | pubmed-meshheading:15094648... | lld:pubmed |
pubmed-article:15094648 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15094648 | pubmed:articleTitle | Treatment of epistaxis in Rendu-Osler-Weber disease by in situ Ethibloc injections. | lld:pubmed |
pubmed-article:15094648 | pubmed:affiliation | Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier et Universitaire d'Angers, 49033 Angers cedex 01, France. sroux-vaillard@libertysurf.fr | lld:pubmed |
pubmed-article:15094648 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15094648 | pubmed:publicationType | Evaluation Studies | lld:pubmed |